|
|
|
|
| LEADER |
03538nam a2200481 4500 |
| 001 |
978-981-10-4466-3 |
| 003 |
DE-He213 |
| 005 |
20191024112300.0 |
| 007 |
cr nn 008mamaa |
| 008 |
171017s2018 si | s |||| 0|eng d |
| 020 |
|
|
|a 9789811044663
|9 978-981-10-4466-3
|
| 024 |
7 |
|
|a 10.1007/978-981-10-4466-3
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RC705-779
|
| 072 |
|
7 |
|a MJL
|2 bicssc
|
| 072 |
|
7 |
|a MED079000
|2 bisacsh
|
| 072 |
|
7 |
|a MJL
|2 thema
|
| 082 |
0 |
4 |
|a 616.2
|2 23
|
| 245 |
1 |
0 |
|a Drug-Induced Lung Injury
|h [electronic resource] /
|c edited by Masayuki Hanaoka, Hiroyuki Nakamura, Kazutetsu Aoshiba.
|
| 250 |
|
|
|a 1st ed. 2018.
|
| 264 |
|
1 |
|a Singapore :
|b Springer Singapore :
|b Imprint: Springer,
|c 2018.
|
| 300 |
|
|
|a VIII, 215 p. 53 illus., 15 illus. in color.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Respiratory Disease Series: Diagnostic Tools and Disease Managements,
|x 2509-5552
|
| 505 |
0 |
|
|a Part I Definition, Pathogenesis, and Epidemiology -- 1. Definition, Pathogenesis and Epidemiology: What is DLI? -- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI? -- 3. Clinical Characteristics of DLI: What are the clinical features of DLI? -- Part II Diagnosis -- 4. Diagnostic Approach for DLI: How is DLI diagnosed? -- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI? -- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted? -- 7. Pathology of DLI: What is the pathological significance of DLI? -- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI? -- Part II Treatment -- 9. Therapeutic Strategies for DLI: How should DLI be treated? -- Part IV Drugs Causing DLI -- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs? -- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs? -- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs? -- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines? -- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?.
|
| 520 |
|
|
|a .
|
| 650 |
|
0 |
|a Respiratory organs-Diseases.
|
| 650 |
1 |
4 |
|a Pneumology/Respiratory System.
|0 http://scigraph.springernature.com/things/product-market-codes/H33134
|
| 700 |
1 |
|
|a Hanaoka, Masayuki.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 700 |
1 |
|
|a Nakamura, Hiroyuki.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 700 |
1 |
|
|a Aoshiba, Kazutetsu.
|e editor.
|4 edt
|4 http://id.loc.gov/vocabulary/relators/edt
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789811044656
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789811044670
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9789811351464
|
| 830 |
|
0 |
|a Respiratory Disease Series: Diagnostic Tools and Disease Managements,
|x 2509-5552
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-981-10-4466-3
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SME
|
| 950 |
|
|
|a Medicine (Springer-11650)
|
